# AR-12286 in Combination With Latanoprost

> **NCT01302249** · PHASE2 · COMPLETED · sponsor: **Aerie Pharmaceuticals** · enrollment: 66 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Latanoprost 0.005%
- **DRUG:** AR-12286 Ophthalmic Solution 0.5%
- **DRUG:** Timolol maleate ophthalmic solution 0.5%

## Key facts

- **NCT ID:** NCT01302249
- **Lead sponsor:** Aerie Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01302249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01302249, "AR-12286 in Combination With Latanoprost". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01302249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*